AU2002214626A1 - Quaternary amines and related inhibitors of factor xa - Google Patents
Quaternary amines and related inhibitors of factor xaInfo
- Publication number
- AU2002214626A1 AU2002214626A1 AU2002214626A AU1462602A AU2002214626A1 AU 2002214626 A1 AU2002214626 A1 AU 2002214626A1 AU 2002214626 A AU2002214626 A AU 2002214626A AU 1462602 A AU1462602 A AU 1462602A AU 2002214626 A1 AU2002214626 A1 AU 2002214626A1
- Authority
- AU
- Australia
- Prior art keywords
- factor
- quaternary amines
- related inhibitors
- inhibitors
- quaternary
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US23633000P | 2000-09-29 | 2000-09-29 | |
| US60/236,330 | 2000-09-29 | ||
| PCT/US2001/042352 WO2002026712A2 (en) | 2000-09-29 | 2001-10-01 | Quaternary amines and related inhibitors of factor xa |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2002214626A1 true AU2002214626A1 (en) | 2002-04-08 |
Family
ID=22889060
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2002214626A Abandoned AU2002214626A1 (en) | 2000-09-29 | 2001-10-01 | Quaternary amines and related inhibitors of factor xa |
Country Status (3)
| Country | Link |
|---|---|
| US (1) | US20040067938A1 (en) |
| AU (1) | AU2002214626A1 (en) |
| WO (1) | WO2002026712A2 (en) |
Families Citing this family (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI290136B (en) | 2000-04-05 | 2007-11-21 | Daiichi Seiyaku Co | Ethylenediamine derivatives |
| US7365205B2 (en) | 2001-06-20 | 2008-04-29 | Daiichi Sankyo Company, Limited | Diamine derivatives |
| DE60335635D1 (en) | 2002-05-22 | 2011-02-17 | Amgen Inc | AMINOPYRIMIDINE DERIVATIVES FOR USE AS VANILLOID RECEPTOR LIGANDS FOR THE TREATMENT OF PAIN |
| TW200410945A (en) | 2002-08-08 | 2004-07-01 | Amgen Inc | Vanilloid receptor ligands and their use in treatments" |
| KR20060110288A (en) * | 2003-10-09 | 2006-10-24 | 밀레니엄 파머슈티컬스 인코퍼레이티드 | Thioether-substituted benzamides as inhibitors of factor xa |
| MY139645A (en) | 2004-02-11 | 2009-10-30 | Amgen Inc | Vanilloid receptor ligands and their use in treatments |
| JP2007522233A (en) | 2004-02-11 | 2007-08-09 | アムジエン・インコーポレーテツド | Vanilloid receptor ligands and their use in therapy |
| US7301022B2 (en) | 2005-02-15 | 2007-11-27 | Amgen Inc. | Vanilloid receptor ligands and their use in treatments |
| UA103319C2 (en) | 2008-05-06 | 2013-10-10 | Глаксосмитклайн Ллк | Thiazole- and oxazole-benzene sulfonamide compounds |
| NZ590283A (en) | 2008-07-14 | 2012-11-30 | Gilead Sciences Inc | Imidazolylpyrimidine compounds as hdac and / or cdk inhibitors |
| WO2010009155A2 (en) | 2008-07-14 | 2010-01-21 | Gilead Colorado, Inc. | Fused heterocyclyc inhibitor compounds |
| EP2303841A1 (en) | 2008-07-14 | 2011-04-06 | Gilead Sciences, Inc. | Oxindolyl inhibitor compounds |
| EP2326622A1 (en) | 2008-07-28 | 2011-06-01 | Gilead Sciences, Inc. | Cycloalkylidene and heterocycloalkylidene histone deacetylase inhibitor compounds |
| FR2942456B1 (en) | 2009-02-25 | 2012-12-07 | Sicma Aero Seat | MODULE FOR AIRCRAFT CABIN AND ASSOCIATED AIRCRAFT CABIN. |
| US8258316B2 (en) | 2009-06-08 | 2012-09-04 | Gilead Sciences, Inc. | Alkanoylamino benzamide aniline HDAC inhibitor compounds |
| AU2010259042A1 (en) | 2009-06-08 | 2011-12-15 | Gilead Sciences, Inc. | Cycloalkylcarbamate benzamide aniline HDAC inhibitor compounds |
| AR081331A1 (en) | 2010-04-23 | 2012-08-08 | Cytokinetics Inc | AMINO- PYRIMIDINES COMPOSITIONS OF THE SAME AND METHODS FOR THE USE OF THE SAME |
| EP2560488B1 (en) | 2010-04-23 | 2015-10-28 | Cytokinetics, Inc. | Certain amino-pyridines and amino-triazines, compositions thereof, and methods for their use |
| AR081626A1 (en) | 2010-04-23 | 2012-10-10 | Cytokinetics Inc | AMINO-PYRIDAZINIC COMPOUNDS, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM AND USE OF THE SAME TO TREAT CARDIAC AND SKELETIC MUSCULAR DISORDERS |
| GB201007203D0 (en) | 2010-04-29 | 2010-06-16 | Glaxo Group Ltd | Novel compounds |
| US8440662B2 (en) | 2010-10-31 | 2013-05-14 | Endo Pharmaceuticals, Inc. | Substituted quinazoline and pyrido-pyrimidine derivatives |
| JP5715713B2 (en) | 2011-03-10 | 2015-05-13 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | Soluble guanylate cyclase activator |
| JP5826393B2 (en) | 2011-08-12 | 2015-12-02 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | Soluble guanylate cyclase activator |
| PE20151001A1 (en) | 2012-09-07 | 2015-07-15 | Boehringer Ingelheim Int | ALCOXYPYRAZOLES AS SOLUBLE GUANILATE CYCLASE ACTIVATORS |
| EA032972B1 (en) | 2014-07-22 | 2019-08-30 | Бёрингер Ингельхайм Интернациональ Гмбх | Heterocyclic carboxylic acids as activators of soluble guanylate cyclase |
| CA3089566A1 (en) | 2018-01-31 | 2019-08-08 | Deciphera Pharmaceuticals, Llc | Combination therapy for the treatment of gastrointestinal stromal tumors |
| US10786485B1 (en) | 2019-03-11 | 2020-09-29 | Nocion Therapeutics, Inc. | Charged ion channel blockers and methods for use |
| CA3129117A1 (en) | 2019-03-11 | 2020-09-17 | Bridget Mccarthy Cole | Charged ion channel blockers and methods for use |
| KR20210145164A (en) | 2019-03-11 | 2021-12-01 | 녹시온 테라퓨틱스 인코포레이티드 | Ester Substituted Ion Channel Blockers and Methods of Use |
| JP2022525856A (en) | 2019-03-11 | 2022-05-20 | ノシオン セラピューティクス，インコーポレイテッド | Charged ion channel blockers and usage |
| CN114615982A (en) | 2019-08-12 | 2022-06-10 | 德西费拉制药有限责任公司 | Ripoctinib for treating gastrointestinal stromal tumor |
| WO2021030405A1 (en) | 2019-08-12 | 2021-02-18 | Deciphera Pharmaceuticals, Llc | Ripretinib for treating gastrointestinal stromal tumors |
| EP4054586A4 (en) | 2019-11-06 | 2023-11-22 | Nocion Therapeutics, Inc. | Charged ion channel blockers and methods for use |
| IL292505A (en) | 2019-11-06 | 2022-06-01 | Nocion Therapeutics Inc | Charged ion channel blockers and methods for use |
| CN115243681A (en) | 2019-12-30 | 2022-10-25 | 德西费拉制药有限责任公司 | Compositions of 1- (4-bromo-5- (1-ethyl-7- (methylamino) -2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl) -2-fluorophenyl) -3-phenylurea |
| LT4084778T (en) | 2019-12-30 | 2024-01-25 | Deciphera Pharmaceuticals, Llc | Amorphous kinase inhibitor formulations and methods of use thereof |
| AU2021236130A1 (en) | 2020-03-11 | 2022-09-22 | Nocion Therapeutics, Inc. | Charged ion channel blockers and methods for use |
| US11779572B1 (en) | 2022-09-02 | 2023-10-10 | Deciphera Pharmaceuticals, Llc | Methods of treating gastrointestinal stromal tumors |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69821985T2 (en) * | 1997-12-19 | 2005-05-04 | Schering Ag | ORTHO-ANTHRANILAMIDE DERIVATIVES AS ANTICOAGULANTS |
| EP1042287B1 (en) * | 1997-12-24 | 2005-04-20 | Aventis Pharma Deutschland GmbH | Indole derivatives as inhibitors of factor xa |
-
2001
- 2001-10-01 US US10/381,925 patent/US20040067938A1/en not_active Abandoned
- 2001-10-01 AU AU2002214626A patent/AU2002214626A1/en not_active Abandoned
- 2001-10-01 WO PCT/US2001/042352 patent/WO2002026712A2/en active Application Filing
Also Published As
| Publication number | Publication date |
|---|---|
| WO2002026712A2 (en) | 2002-04-04 |
| US20040067938A1 (en) | 2004-04-08 |
| WO2002026712A3 (en) | 2002-10-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2002214626A1 (en) | Quaternary amines and related inhibitors of factor xa | |
| HUP0203289A3 (en) | Benzamides and related inhibitors of factor xa | |
| AU2001249399A1 (en) | Isoquinolone inhibitors of factor xa | |
| ZA200306488B (en) | Benzamides and related inhibitors of factor Xa. | |
| AU6762400A (en) | Inhibitors of factor xa | |
| AU5283800A (en) | Inhibitors of factor xa | |
| HK1061851A1 (en) | Gyrase inhibitors and uses thereof | |
| AU5283700A (en) | Inhibitors of factor xa | |
| AU5155500A (en) | Inhibitors of factor xa | |
| AU3857300A (en) | Inhibitors of factor xa | |
| HK1053984B (en) | Gyrase inhibitors and uses thereof | |
| AU2001236605A1 (en) | Indole and benzimidazole inhibitors of factor xa | |
| AU2001273040A1 (en) | Factor xa inhibitors | |
| IL156737A0 (en) | Substituted amine derivatives and methods of use | |
| GB0025782D0 (en) | Use of inhibitors | |
| AU2002225954A1 (en) | Dipeptidylpeptidases and methods of use | |
| AU5284000A (en) | Inhibitors of factor xa | |
| AU2001216218A1 (en) | Heterocyclic analgesic compounds and method of use thereof | |
| AU2001249397A1 (en) | Oxindole inhibitors of factor xa | |
| AU2002306624A1 (en) | Heterocyclic analgesic compounds and methods of use thereof | |
| AU2002337913A1 (en) | Glycosulfopeptide inhibitors and methods of use thereof | |
| AU2002213346A1 (en) | Osteopontin-coated surfaces and methods of use | |
| AU2001294824A1 (en) | Piperazine based inhibitors of factor xa | |
| AU2001281799A1 (en) | Benzamide derivatives and their use as apob-100 and mtp inhibitors | |
| AU2003299815A1 (en) | Matriptase inhibitors and methods of use |